Applications of D-P-Hydroxyphenylglycine in Industrial Manufacturing

D-P-Hydroxyphenylglycine plays a critical role in the synthesis of advanced intermediates for pharmaceuticals, peptide-based bioactives, and fine chemical production. As a direct-duty manufacturer, we support global producers with technical-grade material suitable for implementation in high-purity and cGMP-compliant operations. Below, we detail key industrial application scenarios along with the corresponding regulatory, process, and formulation standards that govern each area.

1. Semi-Synthetic β-Lactam Antibiotic Manufacturing

Major pharmaceutical companies use D-P-Hydroxyphenylglycine as a chiral side chain building block for semi-synthetic antibiotics, including amoxicillin and cefadroxil. Production facilities apply it in multi-step synthesis, where its optical purity impacts the stereochemical integrity and pharmacological activity of the final Active Pharmaceutical Ingredients (APIs). Manufacturers must control impurity profiles, maintain batch traceability, and ensure alignment with pharmacopoeial specifications, especially during coupling and acylation stages.

Industry compliance standards

• USP, EP, JP, and ChP pharmacopoeias
• International Council for Harmonisation (ICH Q7, Q3A/B)
• Current Good Manufacturing Practices (cGMP) US FDA 21 CFR Parts 210/211
• EDQM Certificate of Suitability (CEP) process alignment

Typical usage ratio

• 0.98–1.05 molar equivalents to core nuclei (6-APA or 7-ADCA) depending on reaction stoichiometry optimization
• Adjusted for purity and process yield requirements; excess minimized to prevent downstream hydrolysis by-products

Downstream process integration

• Introduced during enzymatic or chemical condensation with beta-lactam core, preceding crystallization and API finishing
• Coupling often followed by purification under controlled pH and temperature

Final product types

• Amoxicillin trihydrate API
• Cefadroxil monohydrate API
• Bulk intermediate salts for penicillin or cephalosporin derivatives
• Antibiotic oral dosage formulation (later downstream)

2. Peptide Synthesis for Biotech APIs

Biotechnology manufacturers integrate D-P-Hydroxyphenylglycine in solid-phase or solution-phase peptide synthesis to introduce non-canonical amino acid residues conferring desired biological activity or conformational stability. This application calls for strict control of chirality, purity, and protection/deprotection strategies during the construction of complex peptide sequences intended as investigational or commercial biologics. Peptide manufacturers verify enantiopurity and confirm incorporation by LC-MS and NMR prior to downstream lyophilization and packaging.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• Peptide Manufacturer’s Quality System (ISO 9001 or ISO 13485)
• FDA or EMA IND/DMF submission requirements
• Documentation for full traceability on amino acid derivation and supplier audits

Typical usage ratio

• Typically one residue per targeted peptide sequence cycle (1:1 residue/mol or adjusted to resin loading capacity)
• For protected derivatives, loading ranges 0.4–1.2 mmol/g resin depending on peptide length and method

Downstream process integration

• Loaded during Fmoc/Boc-protected amino acid coupling after activation with carbodiimide reagents or other condensing agents
• Purification by RP-HPLC or precipitation before folding and formulation

Final product types

• Custom peptide APIs for R&D studies
• Modified peptide therapeutics
• Diagnostic peptide standards
• Peptide library compounds for screening

3. Chiral Intermediate in Fine Chemical Synthesis

Producers of fine chemicals employ D-P-Hydroxyphenylglycine as a highly selective chiral intermediate for the production of advanced agrochemical compounds, dyes, or specialty polymers. Its defined stereochemistry supports stereoselective reactions in enantio-enriched product development, while compatibility with various protecting groups allows flexible process engineering. Industrial chemists must adhere to prohibition lists and environmental compliance when scaling up to multi-kilogram batches.

Industry compliance standards

• ISO 14001 Environmental Management Systems
• REACH Regulation (EC) No 1907/2006 registration for European supply
• Compliance with local chemical control laws (TSCA, DSL, IECSC etc.)
• Internal QC by NMR, GC, HPLC, and polarimetry

Typical usage ratio

• 1.0–1.2 molar equivalents to the target substrate, based on route-specific demands and desired optical yield
• Stoichiometry refined to minimize waste and improve yield in multi-step syntheses

Downstream process integration

• Enters process during key chiral coupling or asymmetric transformation stages
• Quenched and separated by aqueous/organic extraction prior to further derivatization

Final product types

• Stereoselective intermediates for crop protection chemicals
• Chiral auxiliaries and catalysts
• Intermediate monomers for specialty polymer materials
• Functionalized dye precursors

4. Pharmaceutical Grade Amino Acid for Nutraceuticals

Recognized as a non-proteinogenic amino acid, D-P-Hydroxyphenylglycine finds controlled use in specialized nutraceutical preparations and research-supported food supplements. Nutrition product formulators add it in tightly regulated quantities to functional ingredient blends, focusing on clear labeling and strict residue testing. It requires compliance with food-grade specifications and adherence to labeling and residue limits as set by local nutrition safety authorities.

Industry compliance standards

• Food Chemicals Codex (FCC) for amino acid purity
• ISO 22000 Food Safety Management System
• Food Additives List (FDA 21CFR Part 172 as reference)
• Allergen and trace contaminant certification, if incorporated into oral supplements

Typical usage ratio

• 0.01–0.1% (w/w) in finished nutritional blends, based on intended daily intake and global regulatory upper limits
• Dosing adjusted according to clinical validation and local statutory recommendations

Downstream process integration

• Mixed during premix blending with vitamins, minerals, and functional compounds
• Granulated for tablet pressing or dissolved for liquid supplement batching

Final product types

• Amino acid-fortified dietary supplements
• Sports nutrition premixes
• Oral nutrition powder blends
• Research-use-only nutraceuticals for clinical studies

5. Specialty Chemical Reagent for Analytical Laboratories

Analytical reagent manufacturers use D-P-Hydroxyphenylglycine as a calibration standard and derivatization reagent in methods requiring chiral discrimination or synthetic precursor quantification. Its high purity and batch consistency enable reproducible chromatographic and spectrometric analyses, supporting method development for pharmaceuticals and specialty chemical QC labs. Lot-to-lot analytical performance supports accreditation and participation in proficiency-testing schemes.

Industry compliance standards

• ISO/IEC 17025 Laboratory Accreditation Requirements
• Traceability to Certified Reference Materials (CRMs)
• GLP (Good Laboratory Practice) documentation for internal and regulatory audits
• Analytical grade quality control with certificates of analysis (COA)

Typical usage ratio

• Employed at 0.1–5 mg/mL in solution for calibration standards
• Quantities tailored for derivatization based on analytical method sensitivity and detection limits

Downstream process integration

• Prepared as standard solutions for HPLC/UPLC calibration
• Used as derivatization agent in chiral detection protocols and validation runs

Final product types

• Certified analytical reference standards
• Derivatized samples for chiral impurity analysis
• Custom test kits for pharmaceutical laboratory QC
• Research chemicals for academic investigation